Pharmafile Logo
Pharmafocus logo
Advanced Search

PL Bioscience

Showing 3 posts of 3 posts found.

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026
Manufacturing and Production PL Bioscience

PL BioScience has announced the appointment of Maik Jornitz to its board of directors, effective immediately. Jornitz brings technical expertise, …

Appointment

PL BioScience appoints Oliver Dick as chief technology officer

June 12, 2025
Clinical trials supplies & documentation logistics, Manufacturing and Production, Research and Development Corporate, Devices, Human Platelet Lysate, PL Bioscience, animal-free cell culture, life sciences

PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell …

Appointment

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

May 23, 2025
Research and Development Animal-Free, Artificial Human Platelets, Corporate, DewCell, Haematology, Human Platelet Lysate, Letter of Intent, Oncology, PL Bioscience

PL BioScience and DewCell Biotherapeutics have signed a Letter of Intent (LOI) for the development and supply of artificial human …

News
Press release
The Gateway to Local Adoption Series

Latest content

AstraZeneca’s tozorakimab cuts COPD exacerbations by up to 34% in phase 3 trials

October 4, 2026

Brenntag and dsm-firmenich expand biopharma vitamin partnership

October 4, 2026

CeramTec expands German production capacity for orthopaedic ceramics

October 2, 2026

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026